semaglutide cardiovascular outcomes news 2025 currently not cost-effective for heart patients without diabetes, study finds Wegovy confers reductions in cardiovascular – SELECT Trial

There are no fasting rules, no fluid restrictions, and no daily timing windows to manage

Both involve dysregulation of reward processing

Gradual Weight Loss and Muscle Maintenance For those using GLP-1 drugs primarily for weight loss, microdosing might offer a more gradual weight loss experience, which some individuals believe helps preserve muscle mass

How It Actually Feels (The Real Version) It is like it actually tells my body I was missing something in my brain that let me know like, oh, this is normal hunger

For research protocols, administration is often done on an empty stomach, either in the morning or before bed